GlassScriptPhysician profile
Nathaniel L Hall
NPI 1063695948
$1,704.06
in general payments reported to CMS, 2019-2025
20 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $201 · 2021: $84.31 · 2022: $82.79 · 2023: $233 · 2024: $327 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $412.32 | 2019-2025 | Avvigo Guidance System, Rotapro, Crossboss |
| Biotronik INC. | $305.66 | 2019-2025 | Selectra, Amvia Edge, Pamira |
| Abbott Laboratories | $198.02 | 2024-2025 | Optis, Coroflow |
| Medtronic Vascular, INC. | $138.05 | 2019 | |
| Heartflow, INC. | $120.89 | 2023 | Ffrct |
| Shockwave Medical, INC | $104.21 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $77.42 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $71.02 | 2019-2025 | Camzyos |
| Asahi Intecc USA, INC. | $59.58 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $35.02 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $31.48 | 2019 | |
| Mylan Specialty L.P. | $28.53 | 2019 | |
| Edwards Lifesciences Corporation | $23.44 | 2025 | Evoque |
| Novo Nordisk INC | $16.97 | 2025 | |
| Acist Medical Systems, INC. | $15.25 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.67 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.98 | 2019 | |
| Amgen INC. | $13.53 | 2020 | |
| Gilead Sciences, INC. | $12.39 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.